Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Study sheds light on why many RA patients do not adhere to treatment

Two new studies presented at the European League Against Rheumatism Annual Congress have shed light on why so many patients with Rheumatoid Arthritis (RA) do not adhere to their therapy, even in the early stages of their treatment.

13 Jun 2016

Sexual dysfunction prevalent among RA patients

The results of a study presented today at the European League Against Rheumatism Annual Congress showed that sexual dysfunction is present in more than one-third of patients with rheumatoid arthritis (RA) who are still sexually active, both men and women.

13 Jun 2016

Behavioural intervention could be effective way to improve health of RA patients

The results of a study presented today at the European League Against Rheumatism Annual Congress showed for the first time that a combination of text messages and individual counselling sessions to motivate patients with Rheumatoid Arthritis (RA) to be more active resulted in improved patient-reported clinical outcomes.

13 Jun 2016

Physical workload could increase odds of developing RA

The results of a study presented today at the European League Against Rheumatism Annual Congress showed that prolonged repetitive physical workload increases the risk of developing rheumatoid arthritis (RA).

13 Jun 2016

Findings may help explain why rheumatoid arthritis drugs vary in effect

Researchers at the University of California San Diego School of Medicine, with colleagues in Pennsylvania and China, report that not only are there distinct differences in key cellular processes and molecular signatures between rheumatoid arthritis (RA) and osteoarthritis (OA) but, more surprisingly, there are joint-specific differences in RA.

12 Jun 2016

Study finds link between depression, disease activity and disability in adolescents with JIA

European League Against Rheumatism Annual Congress confirmed a clear association between depression symptom severity and the level of disease activity and disability in adolescent patients with juvenile inflammatory arthritis.

12 Jun 2016

Smoking, obesity lower chances of achieving sustained remission in early RA patients

The results of a study presented today at the European League Against Rheumatism Annual Congress showed that the likelihood of achieving sustained remission in early rheumatoid arthritis (RA) is significantly lower in patients who smoke and who are obese.

10 Jun 2016

Study shows rheumatologists underestimate disease severity in OA patients

The results of a study presented today at the European League Against Rheumatism Annual Congress showed patients with osteoarthritis (OA) are more likely to have the impact of their condition underestimated by rheumatologists than patients with Rheumatoid Arthritis (RA).

10 Jun 2016

BNPs have potential to enable early diagnosis, long-term treatment of RA with minimal side effects

The results of a study presented today at the European League Against Rheumatism Annual Congress showed that tiny particles made of a biodegradable polymer (BNPs -- biodegradable polymer nanoparticles) have the potential to enable early detection and efficient long-term treatment of rheumatoid arthritis (RA), with minimal side effects.

10 Jun 2016

Type 1 diabetes occurs more frequently in patients with JIA

The results of a study involving more than 9,000 patients, presented today at the European League Against Rheumatism Annual Congress showed that Type 1 diabetes occurs significantly more frequently in patients with Juvenile Inflammatory Arthritis (JIA) than in the general population.

10 Jun 2016

Anti-CPP presence in bloodstream of RA patients correlates with drug response

The results of a study presented today at the European League Against Rheumatism Annual Congress showed that the presence of an antibody (anti-CPP ) in the bloodstream of patients with rheumatoid arthritis (RA) correlates with response to different drug treatments.

10 Jun 2016

Antibody-positive patients treated with infliximab less likely to benefit from infliximab biosimilar

The results of a study presented today at the European League Against Rheumatism Annual Congress showed that when antibodies develop in response to the biological treatment Remicade (infliximab), they also cross-react with the biosimilar of infliximab (CT-P13: Inflectra or Remsima).

10 Jun 2016

Study finds differences in hospitalization trends for gout and rheumatoid arthritis

While hospitalizations related to rheumatoid arthritis have dropped considerably over the past two decades, hospitalizations primarily associated with gout have increased dramatically.

8 Jun 2016

Antiinflammatory drug HUMIRA enhances specific TNF function in rheumatoid arthritis patients

Researchers from University College London have discovered that the widely used antiinflammatory drug HUMIRA doesn't just work by inhibiting its target protein, TNF, but by enhancing a particular function of TNF in rheumatoid arthritis patients.

7 Jun 2016

Autoimmune diseases among lung cancer patients may make them unsuitable for immunotherapy

A significant proportion of lung cancer patients also have autoimmune disease, which may make them unsuitable for increasingly popular immunotherapy treatments, a team of researchers at UT Southwestern Medical Center's Harold C. Simmons Comprehensive Cancer Center has found.

6 Jun 2016

Scientists discover master dimmer switches that control activity of immune cells

A person's genetic makeup plays a role in autoimmune diseases such as multiple sclerosis that develop when the body is attacked by its own immune system. But little is known about how immune cells are pushed into overdrive.

3 Jun 2016

First ECHO model helps improve screening and management of autism

Wait lists for a specialist to confirm an autism diagnosis can be agonizing and last months. As the prevalence of autism and autism spectrum disorders increase, so does the demand for a health care system that is fully equipped to respond to the complex needs associated with autism.

1 Jun 2016

European cardiovascular prevention guidelines emphasise population approaches

The European Society of Cardiology has updated its cardiovascular disease prevention guidelines to include, for the first time, population approaches to be implemented by legislators, schools and workplaces.

28 May 2016

TSRI scientists discover new method for harnessing venoms for therapeutic use

There are lessons to be learned from venoms. Scorpions, snakes, snails, frogs and other creatures are thought to produce tens or even hundreds of millions of distinct venoms. These venoms have been honed to strike specific targets in the body.

26 May 2016

SBP scientists discover new regulator of immune responses

Research led by scientists at the Sanford Burnham Prebys Medical Discovery Institute has identified a new regulator of immune responses. The study, published recently in Immunity, sheds new light on why T cells fail to clear chronic infections and eliminate tumors.

26 May 2016

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Study sheds light on why many RA patients do not adhere to treatment

Sexual dysfunction prevalent among RA patients

Behavioural intervention could be effective way to improve health of RA patients

Physical workload could increase odds of developing RA

Findings may help explain why rheumatoid arthritis drugs vary in effect

Study finds link between depression, disease activity and disability in adolescents with JIA

Smoking, obesity lower chances of achieving sustained remission in early RA patients

Study shows rheumatologists underestimate disease severity in OA patients

BNPs have potential to enable early diagnosis, long-term treatment of RA with minimal side effects

Type 1 diabetes occurs more frequently in patients with JIA

Anti-CPP presence in bloodstream of RA patients correlates with drug response

Antibody-positive patients treated with infliximab less likely to benefit from infliximab biosimilar

Study finds differences in hospitalization trends for gout and rheumatoid arthritis

Antiinflammatory drug HUMIRA enhances specific TNF function in rheumatoid arthritis patients

Autoimmune diseases among lung cancer patients may make them unsuitable for immunotherapy

Scientists discover master dimmer switches that control activity of immune cells

First ECHO model helps improve screening and management of autism

European cardiovascular prevention guidelines emphasise population approaches

TSRI scientists discover new method for harnessing venoms for therapeutic use

SBP scientists discover new regulator of immune responses

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in